A new test for pancreatic cysts using cyst fluid
Part of Digestive system clinical trials.
This study tests a new lab test called PanCystPro that looks at fluid taken from a pancreatic cyst during an endoscopic ultrasound. It aims to help doctors better manage your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have a pancreatic cyst that is at least 12 mm in size on a CT or MRI scan.
- Your doctor plans to do an endoscopic ultrasound (EUS) and take a fluid sample (FNA) as part of your standard care.
- You are not diagnosed with pancreatic cancer.
- You are not pregnant or breastfeeding.
- You are not on blood thinners and can safely have the procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for “biomarkers,” or measurable lab signals, in blood and (when available) cyst fluid to understand pancreatic cyst problems and related conditions. It may help doctors better predict what these conditions are and how to manage them.
This trial tests a special camera (confocal laser endomicroscopy) used during an ultrasound-guided needle biopsy to help tell what type of pancreatic cyst is present. It may help doctors decide faster whether surgery is needed.
This study looks for molecular (lab) signals that may show advanced or higher-risk changes in certain pancreatic cysts. It may help doctors better sort which cysts are more concerning and may need closer attention.
This study compares different ways to monitor pancreatic cysts and also measures blood or other test markers to see which approach is more helpful. It may help patients by finding the safest, most effective way to track certain cysts that could otherwise be hard to manage.
This study collects blood and cystic fluid samples from people who are already scheduled for surgery to remove a worrisome pancreatic cyst. The goal is to learn more about these cysts and possibly improve future diagnosis and treatment.
This study builds a “molecular marker” lab model using pancreatic cyst fluid taken during planned pancreatic surgery. It aims to help tell which pancreatic cystic tumors are which, based on fluid analysis.
Hear when a new Pancreatic Cystic Lesions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.